Compounds > cefroxadine

cefroxadine and Bronchitis

cefroxadine has been researched along with Bronchitis* in 2 studies

Other Studies

2 other study(ies) available for cefroxadine and Bronchitis

ArticleYear
[A new oral cephalosporin in the therapy of acute bacterial bronchopneumopathy].
    La Clinica terapeutica, 1982, Oct-31, Volume: 103, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Bronchitis; Cephalosporins; Cephradine; Female; Humans; Male; Middle Aged; Pneumonia

1982
[Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)].
    Minerva medica, 1981, Apr-02, Volume: 72, Issue:13

    CGP 9000 (cefroxadine), a new cephalosporine derived from N-acyl-3-alkoxy-7-amino-3-cefem-4-carboxylic acid for exclusively oral use, has been experimented on 67 patients, 41 adults and 20 children. CGP 9000 appeared to possess good therapeutic activity, even in low doses: its rapid absorption and moderate sero-protein bond are a guarantee of an immediate and almost total bioavailability.

    Topics: Adolescent; Adult; Bacterial Infections; Biological Availability; Bronchitis; Bronchopneumonia; Cephalosporins; Cephradine; Child; Child, Preschool; Cystitis; Drug Evaluation; Erysipelas; Female; Humans; Infant; Male; Middle Aged; Mouth Diseases; Parotitis; Scarlet Fever

1981